Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
Navigating Particle Challenges in Sterile Drugs from Component to Patient
Pfizer recalls 1 lot of Children’s Advil due to overdosing concerns
Tuesday, August 28, 2018
Pfizer is recalling a children’s Advil product over a packaging issue it says could result in overdoses.
Former CFDA chief, Astellas, Huahai and more—FiercePharmaAsia
Friday, August 17, 2018
Former China FDA chief resigns over vaccine scandal; Astellas buys gene therapy specialist Quethera; FDA found problems at valsartan maker Huahai.
Thyroid drugs with ingredient from banned Chinese plant recalled
Wednesday, August 15, 2018
Another Chinese product using potentially substandard ingredients has slipped through the regulatory cracks into the U.S.
FiercePharmaAsia—Pfizer, China-India alliance, Sinovant and more
Friday, July 20, 2018
Pfizer halts production at a legacy Hospira plant; China works to offer Indian drugmakers streamlined access; Roivant's Sinovant debuts with 11 assets.
FDA warns providers to avoid certain valsartan products
Monday, July 16, 2018
Certain valsartan drugs made by Teva, Major Pharmaceuticals and Solco Healthcare—the U.S. subsidiary of the API supplier in question—are being recalled.
FiercePharmaAsia—Biogen-Eisai, Otsuka, Samsung and more
Friday, July 13, 2018
Biogen and Eisai's anti-amyloid candidate shows promise; Otsuka signs two M&A deals; Samsung BioLogics faces criminal probe over Biogen JV agreement.
EMA recalls heart drug made by Chinese firm over possible cancer risk
Monday, July 9, 2018
Zhejiang Huahai Pharmaceutical informed the EMA that it had identified a chemical that might lead to cancer in its valsartan provided to the European market.
Noven recalls thousands of hormone patches that failed specs
Thursday, June 28, 2018
Noven began recalling more than 130,000 boxes of its estradiol adhesive patches in two dose formulations.
Doctor alerts Allergan to package issue for contraceptive pills
Tuesday, May 29, 2018
Some U.S. women given a sample package of an Allergan birth control drug got more than they bargained for: the risk of an unwanted pregnancy.